Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity

Y Mai, J Guo, Y Zhao, S Ma, Y Hou, J Yang - Cellular Immunology, 2020 - Elsevier
Immunization with synthetic mRNA encoding tumor-associated antigens is an emerging
vaccine strategy for the treatment of cancer. In order to prevent mRNA degradation, promote …
被引用次数：110 相关文章

Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity

Y Mai, J Guo, Y Zhao, S Ma, Y Hou… - Cellular …, 2020 - pubmed.ncbi.nlm.nih.gov
Immunization with synthetic mRNA encoding tumor-associated antigens is an emerging
vaccine strategy for the treatment of cancer. In order to prevent mRNA degradation, promote …

Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity.

Y Mai, J Guo, Y Zhao, S Ma, Y Hou, J Yang - Cellular Immunology, 2020 - europepmc.org
Immunization with synthetic mRNA encoding tumor-associated antigens is an emerging
vaccine strategy for the treatment of cancer. In order to prevent mRNA degradation, promote …

Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity

Y Mai, J Guo, Y Zhao, S Ma, Y Hou, J Yang - Cellular Immunology, 2020 - Elsevier
Immunization with synthetic mRNA encoding tumor-associated antigens is an emerging
vaccine strategy for the treatment of cancer. In order to prevent mRNA degradation, promote …